» Articles » PMID: 35955436

Roles of RNA Sensors in Host Innate Response to Influenza Virus and Coronavirus Infections

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Aug 12
PMID 35955436
Authors
Affiliations
Soon will be listed here.
Abstract

Influenza virus and coronavirus are two important respiratory viruses, which often cause serious respiratory diseases in humans and animals after infection. In recent years, highly pathogenic avian influenza virus (HPAIV) and SARS-CoV-2 have become major pathogens causing respiratory diseases in humans. Thus, an in-depth understanding of the relationship between viral infection and host innate immunity is particularly important to the stipulation of effective control strategies. As the first line of defense against pathogens infection, innate immunity not only acts as a natural physiological barrier, but also eliminates pathogens through the production of interferon (IFN), the formation of inflammasomes, and the production of pro-inflammatory cytokines. In this process, the recognition of viral pathogen-associated molecular patterns (PAMPs) by host pattern recognition receptors (PRRs) is the initiation and the most important part of the innate immune response. In this review, we summarize the roles of RNA sensors in the host innate immune response to influenza virus and coronavirus infections in different species, with a particular focus on innate immune recognition of viral nucleic acids in host cells, which will help to develop an effective strategy for the control of respiratory infectious diseases.

Citing Articles

Hyper-Interferon Sensitive Influenza Induces Adaptive Immune Responses and Overcomes Resistance to Anti-PD-1 in Murine Non-Small Cell Lung Cancer.

Du Y, Salehi-Rad R, Zhang T, Crosson W, Abascal J, Chen D Cancer Immunol Res. 2024; 12(12):1765-1779.

PMID: 39325056 PMC: 11612624. DOI: 10.1158/2326-6066.CIR-23-1075.


Viperin mutation is linked to immunity, immune cell dynamics, and metabolic alteration during VHSV infection in zebrafish.

Shanaka K, Jung S, Madushani K, Kim M, Lee J Front Immunol. 2024; 14:1327749.

PMID: 38173722 PMC: 10763233. DOI: 10.3389/fimmu.2023.1327749.


Differential Type-I Interferon Response in Buffy Coat Transcriptome of Individuals Infected with SARS-CoV-2 Gamma and Delta Variants.

da Fonseca G, Cavalcante L, Brustolini O, Luz P, Pires D, Jalil E Int J Mol Sci. 2023; 24(17).

PMID: 37685953 PMC: 10487928. DOI: 10.3390/ijms241713146.


Next-Generation Vaccines: Nanovaccines in the Fight against SARS-CoV-2 Virus and beyond SARS-CoV-2.

Mufamadi M, Ngoepe M, Nobela O, Maluleke N, Phorah B, Methula B Biomed Res Int. 2023; 2023:4588659.

PMID: 37181817 PMC: 10175023. DOI: 10.1155/2023/4588659.


Modified mRNA as a Treatment for Myocardial Infarction.

Wang Y, Wu M, Guo H Int J Mol Sci. 2023; 24(5).

PMID: 36902165 PMC: 10003380. DOI: 10.3390/ijms24054737.

References
1.
Sui H, Chen Q, Imamichi T . Cytoplasmic-translocated Ku70 senses intracellular DNA and mediates interferon-lambda1 induction. Immunology. 2021; 163(3):323-337. PMC: 8207419. DOI: 10.1111/imm.13318. View

2.
Ank N, Paludan S . Type III IFNs: new layers of complexity in innate antiviral immunity. Biofactors. 2009; 35(1):82-7. DOI: 10.1002/biof.19. View

3.
Zhang J, Wu H, Yao X, Zhang D, Zhou Y, Fu B . Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm. Cell Mol Immunol. 2021; 18(5):1305-1307. PMC: 7976727. DOI: 10.1038/s41423-021-00665-0. View

4.
Osterlund P, Pietila T, Veckman V, Kotenko S, Julkunen I . IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J Immunol. 2007; 179(6):3434-42. DOI: 10.4049/jimmunol.179.6.3434. View

5.
de Groot N, Bontrop R . COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males?. Immunogenetics. 2020; 72(5):275-277. PMC: 7186185. DOI: 10.1007/s00251-020-01165-7. View